Navigating the benefits and limitations of current molecular testing options for the clinical identification of disease-causing PCDH19 mutations Poster Brigette Tippin Davis, Kelly Farwell, Melissa Parra, MS, CGC, Ruth Baxter, Stephanie Gandomi
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)